Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

NCT03407651 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A With Inhibitor
Hemophilia B With Inhibitor

Interventions

BIOLOGICAL: Coagulation Factor VIIa variant

Sponsor

Catalyst Biosciences